Amzell B.V. and Amring Pharmaceuticals Inc. Attending 2021 American Epilepsy
02 Dec 2021 //
BUSINESSWIRE
Amzell,B.V., in Collaboration With Amring Pharmaceuticals Inc. Announce
19 Nov 2021 //
BUSINESSWIRE
Amzell, Amring`s AMZ002 Enters Phase III Trial for Infantile Epileptic Disease
19 Nov 2021 //
BUSINESSWIRE
Amzell to begin phase 3 trial of AMZ002 to treat infantile epileptic disease
27 Nov 2020 //
PHARMABIZ